Inductive Bio Connects ADMET Prediction Models to Claude for Drug Discovery

July 01, 2026
Inductive Bio has joined Anthropic's life sciences ecosystem and launched a connector that integrates its ADMET prediction models into Claude, allowing scientists to analyze drug properties directly within the AI assistant.

Inductive Bio announced in a press release that it has joined Anthropic's life sciences ecosystem and introduced a Model Context Protocol connector for Claude by Anthropic. The integration makes Inductive Bio's ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) prediction models available directly within Claude, giving drug discovery scientists access to predictive insights in their existing workflows.

The connector allows users of Claude and Claude Science to request on demand predictions for ADMET properties of chemical structures while reasoning about results through natural language. This feature enables scientists to evaluate how compounds behave in the body alongside other design considerations.

Inductive Bio's ADMET models have been independently validated, ranking first among more than 370 entries in the OpenADMET-ExpansionRx blind challenge. The company stated that chemical structures submitted through Claude are not stored or used to train its models. Researchers can also access Inductive Bio's broader suite of ADMET and pharmacokinetic models or request versions fine tuned to their own chemical datasets.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Life Sciences

07/01
ALR Technologies to Acquire CGM Medical Technology for $45 Million and 200 Million Shares
07/01
Basecamp Research Integrates EDEN Models into Claude Science for Antibiotic and Vaccine Design
07/01
SciBase Files FDA 510(k) to Expand Nevisense Use for Non-Melanoma Skin Cancer
07/01
PreOncology Launches AI-Based Early Cancer Detection Program
07/01
LatusPet Publishes Study on AI Blood Test for Multi-Disease Screening in Dogs

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Market report

AI’s Time-to-Market Quagmire: Why Enterprises Struggle to Scale AI Innovation

ModelOp

The 2025 AI Governance Benchmark Report by ModelOp provides insights from 100 senior AI and data leaders across various industries, highlighting the challenges enterprises face in scaling AI initiatives. The report emphasizes the importance of AI governance and automation in overcoming fragmented systems and inconsistent practices, showcasing how early adoption correlates with faster deployment and stronger ROI.

Read more

You May Also Like